Lacosamide 33342-0304
Product NDC
33342-0304- Manufacturer
- Macleods Pharmaceuticals Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- May 24, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA208466
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(2)
60 TABLET, FILM COATED in 1 BOTTLE (33342-304-09)
100 TABLET, FILM COATED in 1 BOTTLE (33342-304-11)